Pausa pranzo - Società italiana di neurologia
Pausa pranzo - Società italiana di neurologia
Pausa pranzo - Società italiana di neurologia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
27<br />
O<br />
T<br />
T<br />
O<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
THERAPY: A PILOT STUDY<br />
F. PATTI, S. LO FERMO, V. CIMINO, S. MESSINA, E. D'AMICO, S. CAVALLI, C. LEONE, M.<br />
BELLAVIA, C. CAMERANO, M. ZAPPIA (Catania)<br />
867. NATALIZUMAB AND COGNITIVE IMPAIRMENT IN MULTIPLE SCLEROSIS:<br />
BENEFITS FROM TREATMENT<br />
G. PAVAN, S. LA GIOIA, M. ROTTOLI (Milano, Bergamo)<br />
868. STOPPING NATALIZUMAB THERAPY: WHAT HAPPENS. THE REBOUND<br />
MS CENTRE OF FIDENZA CASE REPORTS<br />
I. PESCI, S. MAGNANI, D. CARINI, L. MANNESCHI, A. GUARESCHI, E. MONTANARI<br />
(Fidenza - PR)<br />
869. PUTATIVE MARKERS OF COGNITIVE DECLINE IN MULTIPLE SCLEROSIS:<br />
NEURO PSYCHOLOGICAL TESTING AND QUANTITATIVE ELECTRO -<br />
ENCEPHALOGRAPHY ASSESSMENT<br />
E. PIETROLONGO, D. TRAVAGLINI, G. SEPEDE, M. ONOFRJ, V. DI TOMMASO, D. FARINA,<br />
A. LUGARESI, G. DE LUCA (Chieti)<br />
870. COGNITIVE PERFORMANCE AND QUANTITATIVE MAGNETIC<br />
RESONANCE FEATURES IN MULTIPLE SCLEROSIS PATIENTS TREATED<br />
WITH NATALIZUMAB<br />
E. PORTACCIO, B. GORETTI, M. STROMILLO, V. ZIPOLI, A. GIORGIO, B. HAKIKI, M.<br />
BARTOLOZZI, L. GUIDI, M. GIANNINI, L. PASTÒ, L. RAZZOLINI, G. SIRACUSA, S. SORBI,<br />
A. FEDERICO, N. DE STEFANO, M. AMATO (Firenze, Siena, Empoli - FI)<br />
871. CLINICAL, SEROLOGICAL AND NEURORADIOLOGICAL CHARAC -<br />
TERISATION OF RECURRENT MYELITIS: IDENTIFICATION OF POSSIBLE<br />
PROGNOSTIC FACTORS<br />
M. RADAELLI, V. MARTINELLI, D. DALLA LIBERA, L. MOIOLA, D. PRIVITERA, F.<br />
MARTINELLI BONESCHI, M. RODEGHER, F. SANGALLI, R. FAZIO, G. COMI (Milano)<br />
872. RELAPSING NEUROMYELITIS OPTICA: CLINICAL CHARACTERISTICS<br />
AND IDENTIFICATION OF PROGNOSTIC FACTORS<br />
M. RADAELLI, D. DALLA LIBERA, L. MOIOLA, D. PRIVITERA, F. MARTINELLI BONESCHI,<br />
B. COLOMBO, F. SANGALLI, R. FAZIO, G. COMI, V. MARTINELLI (Milano)<br />
873. OVERCOMING THE CLINICAL-MRI PARADOX OF MS: MRI DATA ASSESSED<br />
WITH A RANDOM FOREST APPROACH<br />
M.A. ROCCA, K. KACAR, M. COPETTI, S. SALA, S. MESAROS, T. STOSIC OPINCAL, D.<br />
CAPUTO, M. ABSINTA, J. DRULOVIC, V. KOSTI, G. COMI, M. FILIPPI (Milano, S.<br />
Giovanni Rotondo - FG, Belgrado - SRB)<br />
874. STARTING IMMUNOMODULANTS SHORTLY AFTER NATALIZUMAB<br />
DISCONTINUATION: INITIAL IMPRESSIONS<br />
F. SANGALLI, L. MOIOLA, M. RADAELLI, V. BARCELLA, V. MARTINELLI, G. COMI (Milano)<br />
875. THE THINNING OF RETINAL NERVE FIBER LAYER IS ASSOCIATED<br />
WITH EXECUTIVE FUNCTION IMPAIRMENT IN MULTIPLE SCLEROSIS<br />
C. SENESI, G. FERRARI, P. IMMOVILLI, F. SALICI, S. MAINI, C. MACALUSO, F. GRANELLA<br />
(Parma, Boston - USA, Piacenza)<br />
876. A MULTIPLE SCLEROSIS RELAPSE PRESENTING AS PAROXYSMAL<br />
HEMIDYSTONIA<br />
A.M. SIMONE, D. FERRARO, E. MERELLI, P. NICHELLI, P. SOLA (Modena)<br />
877. INFORMATION PREFERENCE OF NEWLY-DIAGNOSED MS PATIENTS:<br />
PROSPECTIVE ASSESSMENT WITHIN THE SIMS-TRIAL<br />
A. SOLARI, A. GIORDANO, M. TROJANO, V. MARTINELLI, A. LUGARESI, F. GRANELLA, P.<br />
CONFALONIERI, C. TORTORELLA, I. PLASMATI, M. RADAELLI, D. FARINA, E. DALLA<br />
BELLA, L. MAGGI, M. MESSMER UCCELLI, E. PUCCI, C. BORREANI, R. D'ALESSANDRO<br />
(Milano, Bari, Chieti, Parma, Genova, Macerata, Bologna)<br />
216